InvestorsHub Logo
Followers 27
Posts 1220
Boards Moderated 0
Alias Born 10/04/2011

Re: None

Friday, 11/05/2021 5:23:52 AM

Friday, November 05, 2021 5:23:52 AM

Post# of 403039
$IPIX has taken every step necessary to ensure that this trial would be adequate for FDA. From additional clinical testing to establish EC50/90 values, PRE-IND meetings, requesting FDA Fast Track designation and achieving, and tests on multiple cell lines…IPIX has spent the time and money to do it right.

If it’s OK with the FDA, it’s OK with me.

“WAKEFIELD, MA – November 2, 2020 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today receipt of written feedback from the U.S. Food and Drug Administration (FDA) that is in general agreement with the Company’s planned clinical trial for Brilacidin, a defensin-mimetic drug candidate, for the treatment of COVID-19. The FDA response completes the Pre-Investigational New Drug (Pre-IND) process.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News